These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11879161

  • 1. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
    Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RM, LaVange LM, Klein DN, Fawcett J, Harrison W.
    Arch Gen Psychiatry; 2002 Mar; 59(3):233-9. PubMed ID: 11879161
    [Abstract] [Full Text] [Related]

  • 2. Sertraline versus imipramine to prevent relapse in chronic depression.
    Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB.
    J Affect Disord; 2001 Jun; 65(1):27-36. PubMed ID: 11426506
    [Abstract] [Full Text] [Related]

  • 3. Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study.
    Baca E, González de Chávez M, García-Toro M, Pérez-Arnau F, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):493-500. PubMed ID: 12691786
    [Abstract] [Full Text] [Related]

  • 4. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
    Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM.
    J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
    [Abstract] [Full Text] [Related]

  • 5. Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status.
    Harvey AT, Silkey BS, Kornstein SG, Clary CM.
    J Clin Psychiatry; 2007 Jun; 68(6):951-8. PubMed ID: 17592923
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality.
    Hellerstein DJ, Kocsis JH, Chapman D, Stewart JW, Harrison W.
    Am J Psychiatry; 2000 Sep; 157(9):1436-44. PubMed ID: 10964860
    [Abstract] [Full Text] [Related]

  • 7. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB.
    Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
    [Abstract] [Full Text] [Related]

  • 8. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB.
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [Abstract] [Full Text] [Related]

  • 9. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W.
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
    Kocsis JH, Zisook S, Davidson J, Shelton R, Yonkers K, Hellerstein DJ, Rosenbaum J, Halbreich U.
    Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
    Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J.
    J Affect Disord; 2002 Apr; 68(2-3):317-30. PubMed ID: 12063159
    [Abstract] [Full Text] [Related]

  • 17. The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial.
    Schweizer E, Rynn M, Mandos LA, Demartinis N, García-España F, Rickels K.
    Int Clin Psychopharmacol; 2001 May; 16(3):137-43. PubMed ID: 11354235
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
    Fava M, Nierenberg AA, Quitkin FM, Zisook S, Pearlstein T, Stone A, Rosenbaum JF.
    Psychopharmacol Bull; 1997 May; 33(1):101-3. PubMed ID: 9133758
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.